The invention describes vaccine compositions combined in the same proportion with the extracellular domains of growth factor receptors Her1 and Her2 or fragments thereof and furthermore very small size proteoliposomes derived from proteins of the outer membrane of Neisseria meningitidis and GM3 ganglioside (VSSP- GM3), administered subcutaneously. The disclosed compositions, which induce the production of antibodies are used for the treatment of malignancies and offer advantages because they completely remove the tumor mass thus preventing tumor regression due to the emergence of resistant variants.本發明描述經由皮下投予之疫苗組成物,該疫苗組成物具有以相同比例組合之生長因子受體Her1和Her2之胞外結構域或彼等之片段及源自腦膜炎奈瑟氏球菌(Neisseria meningitidis)之外膜蛋白和GM3神經節苷脂的非常小尺寸之蛋白脂質體(VSSP-GM3)。本發明所揭示之誘導抗體製造的組成物係用於治療惡性腫瘤並提供益處,因該抗體完全去除腫瘤塊,從而防止因抗性變體的出現所造成之腫瘤消退。